NEVVI Medicare utilization intelligence
or

← back

Provider profile

LEVINE, JAMES DO

Rheumatology · NPI 1093793838 · GREELEY, CO

1
Groups
20
Codes · 2024
183,349
Disclosed services

LEVINE, JAMES is a Rheumatology in GREELEY, CO, a member of 1 medical group, who billed 20 distinct codes to Medicare Part B in 2024.

Groups: POUDRE VALLEY MEDICAL GROUP LLC (COLORADO SPRINGS, CO)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

183,349
disclosed services
20
codes billed to Medicare Part B
Prior year · CY2023 140,306 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3262 Injection, tocilizumab, 1 mg
J3111 Injection, romosozumab-aqqg, 1 mg
J1602 Injection, golimumab, 1 mg, for intravenous use
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J0897 Injection, denosumab, 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96413 Administration of chemotherapy into vein, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96372 Injection of drug or substance under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
96375 Injection of additional new drug or substance into vein
J2919 Injection, methylprednisolone sodium succinate, 5 mg
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
20610 Aspiration and/or injection of fluid from large joint
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.